Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


28.01.2019

1 Am J Gastroenterol
2 Eur J Gastroenterol Hepatol
1 J Gen Virol
1 J Hepatol
3 J Viral Hepat
2 J Virol
2 Lancet Gastroenterol Hepatol
2 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. LAIQUE SN, Vargas HE
    Hepatitis C Virus: No Longer a Barrier to Oncology Care.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000095.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  2. EL-KHAYAT H, Kamal EM, Yakoot M, Gawad MA, et al
    Effectiveness of 8-week sofosbuvir/ledipasvir in the adolescent chronic hepatitis C-infected patients.
    Eur J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1097/MEG.0000000000001360.
    PubMed     Text format     Abstract available

  3. ORMECI N, Sezgin O, Karaali R, Aygen B, et al
    Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences.
    Eur J Gastroenterol Hepatol. 2019 Jan 21. doi: 10.1097/MEG.0000000000001334.
    PubMed     Text format     Abstract available


    J Gen Virol

  4. BERNIER A, Sagan SM
    Beyond sites 1 and 2, miR-122 target sites in the HCV genome have negligible contributions to HCV RNA accumulation in cell culture.
    J Gen Virol. 2019 Jan 17. doi: 10.1099/jgv.0.001217.
    PubMed     Text format     Abstract available


    J Hepatol

  5. PAPALUCA T, McDonald L, Craigie A, Gibson A, et al
    Outcomes of treatment for hepatitis C in prisoners using a nurse-led, state-wide model of care.
    J Hepatol. 2019 Jan 14. pii: S0168-8278(19)30024.
    PubMed     Text format     Abstract available


    J Viral Hepat

  6. RUANE P, Strasser SI, Gane EJ, Hyland RH, et al
    Sofosbuvir/Velpatasvir/Voxilaprevir for Patients with HCV Who Previously Received a Sofosbuvir/Velpatasvir-Containing Regimen: Results from a Retreatment Study.
    J Viral Hepat. 2019 Jan 21. doi: 10.1111/jvh.13067.
    PubMed     Text format     Abstract available

  7. HARRIS RJ, Harris H, Mandal S, Ramsay M, et al
    Monitoring the hepatitis C epidemic in England and evaluating intervention scale-up using routinely collected data.
    J Viral Hepat. 2019 Jan 21. doi: 10.1111/jvh.13063.
    PubMed     Text format     Abstract available

  8. GIROMETTI N, Devitt E, Phillips J, Nelson M, et al
    High rates of unprotected anal sex and use of generic direct-acting antivirals in a cohort of MSM with acute HCV infection.
    J Viral Hepat. 2019 Jan 19. doi: 10.1111/jvh.13066.
    PubMed     Text format     Abstract available


    J Virol

  9. URBANOWICZ RA, Wang R, Schiel JE, Keck ZY, et al
    Antigenicity and Immunogenicity of Differentially Glycosylated HCV E2 Envelope Proteins Expressed in Mammalian and Insect Cells.
    J Virol. 2019 Jan 16. pii: JVI.01403-18. doi: 10.1128/JVI.01403.
    PubMed     Text format     Abstract available

  10. MARIN MQ, Perez P, Ljungberg K, Sorzano COS, et al
    Potent Anti-Hepatitis C (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-launched RNA Replicons and MVA-HCV.
    J Virol. 2019 Jan 23. pii: JVI.00055-19. doi: 10.1128/JVI.00055.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  11. MARTINELLO M, Matthews GV
    Management of acute HCV in the era of direct-acting antivirals: implications for elimination.
    Lancet Gastroenterol Hepatol. 2019 Jan 16. pii: S2468-1253(19)30001.
    PubMed     Text format    

  12. BOEREKAMPS A, De Weggheleire A, van den Berk GE, Lauw FN, et al
    Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.
    Lancet Gastroenterol Hepatol. 2019 Jan 16. pii: S2468-1253(18)30414.
    PubMed     Text format     Abstract available


    PLoS One

  13. MANE A, Sacks J, Sharma S, Singh H, et al
    Evaluation of five rapid diagnostic tests for detection of antibodies to hepatitis C virus (HCV): A step towards scale-up of HCV screening efforts in India.
    PLoS One. 2019;14:e0210556.
    PubMed     Text format     Abstract available

  14. CHEN YY, Fang WH, Wang CC, Kao TW, et al
    Increased body fat percentage in patients with hepatitis B and C virus infection.
    PLoS One. 2018;13:e0200164.
    PubMed     Text format     Abstract available


    Transplant Proc

  15. GARCIA-PAJARES F, Tejedor-Tejada J, Torres-Yuste R, Almohalla-Alvarez C, et al
    Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30877.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: